FDA rejects Galderma’s liquid neurotoxin due to CMC issues
Galderma’s neurotoxin for frown lines and crow’s feet was rejected by the FDA on Monday after finding issues with its chemistry …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
